More recently, cten was considered to be a potential tumor suppressor by interacting with DLC-1 (deleted-in-liver-cancer-1), a member of RhoGTPase activating protein (GAP) family known to have suppressive activities in tumorigenicity and cancer metastasis [12], [13], [15]–[18]. The gene discussed is TNS4; the disease is neoplasm.